CRISPR Therapeutics (CRSPN.MX) Q2 2025 Earnings

6MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-31.01
-23.69
-16.36
-9.04

Details

Expected EPS
-24.408288084600002
Actual EPS
-31.011924000000004
Surprise EPS
-6.6
Surprise Percent
+27.05%

Description

CRISPR Therapeutics (CRSPN.MX) has reported earnings of -31.011924000000004 per share for Q2 2025.

0 Comments

Share your thoughts